TwinBeech Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-33,604
| Closed | -$95.4K | – | 518 |
|
|
2024
Q1 | $95.4K | Sell |
33,604
-132,840
| -80% | -$377K | ﹤0.01% | 508 |
|
|
2023
Q4 | $2.45M | Buy |
166,444
+84,860
| +104% | +$1.25M | 0.04% | 373 |
|
|
2023
Q3 | $1.49M | Sell |
81,584
-74,464
| -48% | -$1.36M | 0.03% | 443 |
|
|
2023
Q2 | $3.37M | Buy |
156,048
+24,276
| +18% | +$524K | 0.07% | 315 |
|
|
2023
Q1 | $3.87M | Buy |
+131,772
| New | +$3.87M | 0.08% | 278 |
|